AskTheDate.com
Back to calendar

Immix Biopharma, Inc. (IMMX) Earnings

IMMX reports earnings on Wednesday, September 2, 2026

earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.18
Actual EPS: $-0.18
EPS surprise: 0.30%
Company overview
Market Cap$592.3M
PriceUSD 8.32
EPS (TTM)-0.92
52-week high12.14
52-week low1.94
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees21